Evidence map›Paper›PMID 27393338›Full record

ArticleBMC genomics2016

The next generation of target capture technologies - large DNA fragment enrichment and sequencing determines regional genomic variation of high complexity.

Johannes Dapprich, Deborah Ferriola, Kate Mackiewicz, Peter M Clark, Eric Rappaport, Monica D'Arcy, Ariella Sasson, Xiaowu Gai, Jonathan Schug, Klaus H Kaestner and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Insights Into Spatial Transcriptomics: Exploring Recent Technical Developments and Their Diverse Applications.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Article
  3. Article
  4. Typing ofFrontiers in microbiology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Johannes DapprichGeneration Biotech, Lawrenceville, NJ, 08648, USA. jdapprich@generationbiotech.com.
Deborah FerriolaGeneration Biotech, Lawrenceville, NJ, 08648, USA.
Kate MackiewiczDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Peter M ClarkDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Eric RappaportNucleic Acids & Protein Core Facility, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Monica D'ArcyThe Center for Biomedical Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Ariella SassonThe Center for Biomedical Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Xiaowu GaiThe Center for Biomedical Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Jonathan SchugDepartment of Genetics, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Klaus H KaestnerDepartment of Genetics, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Dimitri MonosDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. monosd@email.chop.edu.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USGeneration Biotech (United States) · US

Funding

A Rapid Method for HLA-typing by HaplotypingR44AI051036 · NIAID · GENERATION BIOTECH, LLC · PI DAPPRICH, JOHANNES · 2004 to 2006
$2.8M
NIAID NIH HHS R44 AI051036
6 · The paper itself

Abstract

backgroundThe ability to capture and sequence large contiguous DNA fragments represents a significant advancement towards the comprehensive characterization of complex genomic regions. While emerging sequencing platforms are capable of producing several kilobases-long reads, the fragment sizes generated by current DNA target enrichment technologies remain a limiting factor, producing DNA fragments generally shorter than 1 kbp. The DNA enrichment methodology described herein, Region-Specific Extraction (RSE), produces DNA segments in excess of 20 kbp in length. Coupling this enrichment method to appropriate sequencing platforms will significantly enhance the ability to generate complete and accurate sequence characterization of any genomic region without the need for reference-based assembly.

resultsRSE is a long-range DNA target capture methodology that relies on the specific hybridization of short (20-25 base) oligonucleotide primers to selected sequence motifs within the DNA target region. These capture primers are then enzymatically extended on the 3'-end, incorporating biotinylated nucleotides into the DNA. Streptavidin-coated beads are subsequently used to pull-down the original, long DNA template molecules via the newly synthesized, biotinylated DNA that is bound to them. We demonstrate the accuracy, simplicity and utility of the RSE method by capturing and sequencing a 4 Mbp stretch of the major histocompatibility complex (MHC). Our results show an average depth of coverage of 164X for the entire MHC. This depth of coverage contributes significantly to a 99.94 % total coverage of the targeted region and to an accuracy that is over 99.99 %.

conclusionsRSE represents a cost-effective target enrichment method capable of producing sequencing templates in excess of 20 kbp in length. The utility of our method has been proven to generate superior coverage across the MHC as compared to other commercially available methodologies, with the added advantage of producing longer sequencing templates amenable to DNA sequencing on recently developed platforms. Although our demonstration of the method does not utilize these DNA sequencing platforms directly, our results indicate that the capture of long DNA fragments produce superior coverage of the targeted region.

Indexed as

Genetic VariationGenome, HumanHigh-Throughput Nucleotide SequencingComparative Genomic HybridizationDatabases, GeneticDNA PrimersGenomicsHumansMajor Histocompatibility ComplexNucleic Acid HybridizationReal-Time Polymerase Chain ReactionSequence Analysis, DNADNA PrimersDNA sequencingDNA target captureGenomic resequencingMHC haplotypeTargeted enrichment

Identifiers

PMID27393338
PMCPMC4938946
OpenAlexW2462868993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.